 Mayra Maymone
Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatology | 18 | 2024 | 115 | 4.570 |
Why?
| | Beauty | 8 | 2023 | 19 | 2.970 |
Why?
| | Hyperpigmentation | 8 | 2021 | 24 | 2.820 |
Why?
| | Skin Diseases | 8 | 2022 | 143 | 1.950 |
Why?
| | Body Dysmorphic Disorders | 5 | 2023 | 11 | 1.920 |
Why?
| | Social Media | 5 | 2023 | 144 | 1.650 |
Why?
| | Sunscreening Agents | 5 | 2022 | 24 | 1.580 |
Why?
| | Cosmetic Techniques | 8 | 2023 | 19 | 1.420 |
Why?
| | Melanosis | 4 | 2024 | 18 | 1.390 |
Why?
| | Leprosy | 2 | 2020 | 14 | 1.360 |
Why?
| | Skin | 9 | 2022 | 737 | 1.220 |
Why?
| | Mouth Mucosa | 2 | 2018 | 89 | 1.200 |
Why?
| | Skin Pigmentation | 5 | 2022 | 49 | 1.190 |
Why?
| | Authorship | 4 | 2024 | 44 | 1.070 |
Why?
| | Chemexfoliation | 2 | 2024 | 2 | 1.060 |
Why?
| | Bibliometrics | 5 | 2022 | 53 | 1.060 |
Why?
| | Body Image | 5 | 2023 | 80 | 1.060 |
Why?
| | Croton Oil | 1 | 2024 | 3 | 0.910 |
Why?
| | Face | 4 | 2019 | 168 | 0.830 |
Why?
| | Publishing | 4 | 2024 | 139 | 0.820 |
Why?
| | Esthetics | 5 | 2023 | 50 | 0.760 |
Why?
| | Facial Dermatoses | 2 | 2019 | 16 | 0.680 |
Why?
| | Sunburn | 1 | 2019 | 28 | 0.660 |
Why?
| | Quality of Life | 6 | 2021 | 2706 | 0.640 |
Why?
| | Rhinoplasty | 1 | 2019 | 27 | 0.620 |
Why?
| | Communication Barriers | 1 | 2019 | 101 | 0.610 |
Why?
| | Foreign-Body Reaction | 1 | 2018 | 26 | 0.610 |
Why?
| | Mouth | 1 | 2018 | 81 | 0.610 |
Why?
| | Mouth Neoplasms | 1 | 2018 | 86 | 0.590 |
Why?
| | Color Perception | 1 | 2017 | 22 | 0.580 |
Why?
| | Environment, Controlled | 1 | 2017 | 20 | 0.580 |
Why?
| | Sickness Impact Profile | 1 | 2017 | 54 | 0.570 |
Why?
| | Sunlight | 2 | 2019 | 71 | 0.560 |
Why?
| | Object Attachment | 1 | 2017 | 41 | 0.560 |
Why?
| | Facial Recognition | 1 | 2017 | 30 | 0.560 |
Why?
| | Precancerous Conditions | 1 | 2018 | 164 | 0.550 |
Why?
| | Humans | 62 | 2024 | 128896 | 0.540 |
Why?
| | Mobile Applications | 1 | 2019 | 158 | 0.530 |
Why?
| | Perception | 1 | 2019 | 336 | 0.530 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 322 | 0.520 |
Why?
| | Outpatients | 1 | 2019 | 366 | 0.520 |
Why?
| | Light | 2 | 2022 | 355 | 0.510 |
Why?
| | Photography | 4 | 2021 | 99 | 0.500 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2020 | 1264 | 0.480 |
Why?
| | Affect | 1 | 2017 | 287 | 0.470 |
Why?
| | Psychiatry | 1 | 2017 | 180 | 0.460 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 349 | 0.460 |
Why?
| | Cross-Sectional Studies | 10 | 2024 | 5032 | 0.450 |
Why?
| | Delivery of Health Care | 2 | 2021 | 896 | 0.410 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 5355 | 0.390 |
Why?
| | Research Design | 1 | 2018 | 1038 | 0.390 |
Why?
| | Biomedical Research | 1 | 2018 | 654 | 0.380 |
Why?
| | Female | 26 | 2024 | 68162 | 0.370 |
Why?
| | Health Behavior | 1 | 2017 | 732 | 0.370 |
Why?
| | Dermatologists | 2 | 2021 | 3 | 0.360 |
Why?
| | Education, Medical, Continuing | 4 | 2018 | 123 | 0.350 |
Why?
| | Diagnosis, Differential | 3 | 2020 | 1435 | 0.350 |
Why?
| | Adult | 15 | 2024 | 35361 | 0.350 |
Why?
| | Male | 25 | 2024 | 63146 | 0.350 |
Why?
| | Skin Neoplasms | 4 | 2021 | 828 | 0.330 |
Why?
| | Biopsy, Needle | 2 | 2018 | 191 | 0.300 |
Why?
| | Dermal Fillers | 3 | 2022 | 3 | 0.300 |
Why?
| | Middle Aged | 13 | 2024 | 30977 | 0.290 |
Why?
| | Risk Assessment | 4 | 2018 | 3286 | 0.250 |
Why?
| | Time Factors | 3 | 2024 | 6568 | 0.250 |
Why?
| | Patient Satisfaction | 2 | 2019 | 639 | 0.240 |
Why?
| | Croton | 1 | 2024 | 1 | 0.230 |
Why?
| | Young Adult | 7 | 2020 | 12286 | 0.230 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1694 | 0.230 |
Why?
| | Phenol | 1 | 2024 | 19 | 0.230 |
Why?
| | Sex Factors | 3 | 2020 | 1947 | 0.210 |
Why?
| | Periodicals as Topic | 3 | 2024 | 209 | 0.200 |
Why?
| | History, 20th Century | 3 | 2019 | 294 | 0.200 |
Why?
| | Raynaud Disease | 1 | 2022 | 6 | 0.200 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1523 | 0.200 |
Why?
| | Comprehension | 2 | 2020 | 167 | 0.190 |
Why?
| | Myofibromatosis | 1 | 2021 | 10 | 0.190 |
Why?
| | Carcinoma, Basal Cell | 2 | 2020 | 73 | 0.190 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2021 | 6 | 0.190 |
Why?
| | Endocarditis, Bacterial | 1 | 2022 | 42 | 0.190 |
Why?
| | Cultural Characteristics | 2 | 2018 | 63 | 0.190 |
Why?
| | Laser Therapy | 1 | 2023 | 126 | 0.180 |
Why?
| | Sunbathing | 1 | 2021 | 14 | 0.180 |
Why?
| | Peripheral Vascular Diseases | 1 | 2022 | 104 | 0.180 |
Why?
| | Keratinocytes | 2 | 2019 | 240 | 0.180 |
Why?
| | Age Factors | 2 | 2019 | 3133 | 0.180 |
Why?
| | Incidence | 4 | 2020 | 2634 | 0.180 |
Why?
| | Subcutaneous Tissue | 1 | 2020 | 23 | 0.180 |
Why?
| | Scleroderma, Localized | 1 | 2020 | 8 | 0.170 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 2020 | 7 | 0.170 |
Why?
| | Global Health | 2 | 2020 | 317 | 0.170 |
Why?
| | Waist-Hip Ratio | 1 | 2020 | 36 | 0.170 |
Why?
| | Endemic Diseases | 1 | 2020 | 31 | 0.170 |
Why?
| | Body Fat Distribution | 1 | 2020 | 49 | 0.170 |
Why?
| | Knowledge | 1 | 2020 | 49 | 0.170 |
Why?
| | Prevalence | 3 | 2023 | 2540 | 0.170 |
Why?
| | Acne Vulgaris | 1 | 2020 | 27 | 0.170 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2022 | 525 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 1968 | 0.160 |
Why?
| | Adolescent | 7 | 2021 | 20197 | 0.160 |
Why?
| | Skin Care | 1 | 2019 | 21 | 0.160 |
Why?
| | Genitalia | 1 | 2019 | 30 | 0.160 |
Why?
| | Cicatrix | 1 | 2020 | 56 | 0.160 |
Why?
| | Sex Reassignment Procedures | 1 | 2019 | 2 | 0.160 |
Why?
| | Fees and Charges | 1 | 2019 | 10 | 0.160 |
Why?
| | Skin Aging | 1 | 2019 | 21 | 0.160 |
Why?
| | Scleroderma, Systemic | 1 | 2020 | 109 | 0.160 |
Why?
| | Internationality | 1 | 2020 | 148 | 0.160 |
Why?
| | Skin Diseases, Papulosquamous | 1 | 2019 | 2 | 0.160 |
Why?
| | Ultraviolet Rays | 2 | 2022 | 385 | 0.160 |
Why?
| | Skin Diseases, Genetic | 1 | 2019 | 11 | 0.160 |
Why?
| | Culture | 1 | 2020 | 125 | 0.160 |
Why?
| | Drug Resistance, Bacterial | 1 | 2020 | 170 | 0.160 |
Why?
| | Dermatologic Agents | 1 | 2019 | 66 | 0.160 |
Why?
| | Social Networking | 1 | 2019 | 32 | 0.160 |
Why?
| | Community Pharmacy Services | 1 | 2019 | 47 | 0.150 |
Why?
| | Medicine, Chinese Traditional | 1 | 2018 | 1 | 0.150 |
Why?
| | Videoconferencing | 1 | 2019 | 62 | 0.150 |
Why?
| | Psychology, Adolescent | 1 | 2018 | 63 | 0.150 |
Why?
| | Habits | 1 | 2018 | 43 | 0.150 |
Why?
| | China | 1 | 2019 | 187 | 0.150 |
Why?
| | Databases, Factual | 2 | 2021 | 1289 | 0.150 |
Why?
| | Mouth Diseases | 1 | 2018 | 45 | 0.150 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 537 | 0.150 |
Why?
| | Acupuncture Therapy | 1 | 2018 | 18 | 0.150 |
Why?
| | Patients | 1 | 2019 | 167 | 0.150 |
Why?
| | Erythema | 1 | 2018 | 28 | 0.150 |
Why?
| | Cell Phone | 1 | 2018 | 69 | 0.150 |
Why?
| | Physical Examination | 1 | 2019 | 237 | 0.150 |
Why?
| | Peer Review | 1 | 2018 | 46 | 0.140 |
Why?
| | Treatment Outcome | 5 | 2024 | 10239 | 0.140 |
Why?
| | Language | 1 | 2020 | 283 | 0.140 |
Why?
| | Peer Review, Research | 1 | 2018 | 40 | 0.140 |
Why?
| | Cost of Illness | 1 | 2020 | 290 | 0.140 |
Why?
| | History, 19th Century | 1 | 2017 | 56 | 0.140 |
Why?
| | Health Status Disparities | 1 | 2020 | 242 | 0.140 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2018 | 70 | 0.140 |
Why?
| | Sun Protection Factor | 1 | 2017 | 1 | 0.140 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1020 | 0.140 |
Why?
| | Recurrence | 1 | 2020 | 1013 | 0.140 |
Why?
| | Writing | 1 | 2018 | 92 | 0.130 |
Why?
| | Melanoma | 2 | 2020 | 735 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2018 | 259 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 334 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 764 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2018 | 327 | 0.120 |
Why?
| | Motivation | 1 | 2019 | 541 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2019 | 722 | 0.110 |
Why?
| | Internet | 1 | 2018 | 616 | 0.110 |
Why?
| | Patient Education as Topic | 1 | 2018 | 734 | 0.110 |
Why?
| | Health Personnel | 1 | 2019 | 642 | 0.110 |
Why?
| | Risk Factors | 3 | 2020 | 9792 | 0.090 |
Why?
| | Aged | 6 | 2020 | 22035 | 0.090 |
Why?
| | Professional Practice Gaps | 2 | 2020 | 12 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2013 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1701 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4917 | 0.080 |
Why?
| | Aged, 80 and over | 4 | 2020 | 7050 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6247 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2694 | 0.060 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 729 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 699 | 0.060 |
Why?
| | Skin Diseases, Viral | 1 | 2024 | 5 | 0.060 |
Why?
| | Chilblains | 1 | 2024 | 3 | 0.060 |
Why?
| | Skin Diseases, Vascular | 1 | 2024 | 9 | 0.060 |
Why?
| | RNA Virus Infections | 1 | 2024 | 13 | 0.060 |
Why?
| | RNA Viruses | 1 | 2024 | 33 | 0.050 |
Why?
| | Physicians, Women | 1 | 2024 | 69 | 0.050 |
Why?
| | Exanthema | 1 | 2024 | 76 | 0.050 |
Why?
| | Phototherapy | 1 | 2023 | 28 | 0.050 |
Why?
| | Lip | 1 | 2022 | 22 | 0.050 |
Why?
| | Lasers | 1 | 2023 | 131 | 0.050 |
Why?
| | Scalp | 1 | 2021 | 34 | 0.050 |
Why?
| | Skin Cream | 1 | 2021 | 12 | 0.050 |
Why?
| | Consumer Behavior | 1 | 2022 | 71 | 0.050 |
Why?
| | Hydroquinones | 1 | 2021 | 29 | 0.050 |
Why?
| | Prescriptions | 1 | 2021 | 68 | 0.050 |
Why?
| | Lasers, Dye | 1 | 2020 | 3 | 0.040 |
Why?
| | Global Burden of Disease | 1 | 2020 | 18 | 0.040 |
Why?
| | Sexism | 1 | 2021 | 54 | 0.040 |
Why?
| | Boston | 1 | 2020 | 89 | 0.040 |
Why?
| | Lasers, Solid-State | 1 | 2020 | 23 | 0.040 |
Why?
| | Child | 1 | 2019 | 20824 | 0.040 |
Why?
| | Psychology, Social | 1 | 2019 | 12 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 247 | 0.040 |
Why?
| | Needles | 1 | 2020 | 57 | 0.040 |
Why?
| | Administration, Cutaneous | 1 | 2019 | 130 | 0.040 |
Why?
| | Melanocytes | 1 | 2019 | 66 | 0.040 |
Why?
| | Surgery, Plastic | 1 | 2019 | 31 | 0.040 |
Why?
| | Standard of Care | 1 | 2019 | 70 | 0.040 |
Why?
| | History, 21st Century | 1 | 2019 | 182 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 20 | 0.040 |
Why?
| | Cosmetics | 1 | 2018 | 8 | 0.040 |
Why?
| | Mast Cells | 1 | 2019 | 142 | 0.040 |
Why?
| | Social Class | 1 | 2020 | 256 | 0.040 |
Why?
| | Emigrants and Immigrants | 1 | 2020 | 120 | 0.040 |
Why?
| | Color | 1 | 2018 | 73 | 0.040 |
Why?
| | Educational Status | 1 | 2020 | 458 | 0.040 |
Why?
| | Minority Groups | 1 | 2019 | 240 | 0.040 |
Why?
| | Life Style | 1 | 2020 | 459 | 0.040 |
Why?
| | Massachusetts | 1 | 2018 | 159 | 0.040 |
Why?
| | Editorial Policies | 1 | 2018 | 47 | 0.040 |
Why?
| | Infant, Premature | 1 | 2021 | 540 | 0.040 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 527 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1516 | 0.030 |
Why?
| | Transgender Persons | 1 | 2019 | 174 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 502 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 626 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2019 | 504 | 0.030 |
Why?
| | Pilot Projects | 1 | 2019 | 1545 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2018 | 1858 | 0.030 |
Why?
| | Communication | 1 | 2019 | 839 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3042 | 0.030 |
Why?
| | United States | 2 | 2020 | 13975 | 0.030 |
Why?
| | Smoking | 1 | 2020 | 1501 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2019 | 14546 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1101 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5704 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3787 | 0.020 |
Why?
| | Exercise | 1 | 2020 | 1923 | 0.020 |
Why?
|
|
Maymone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|